LOS ANGELES, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

LOS ANGELES, Sept. 18, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investo

New class action for GoDaddy (GDDY) urges investors to seek recovery for alleged securities fraud vi

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogn

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

A chronology of dated disclosure events allegedly shows Fractyl Health promoting Revita DMR weight-m

NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has bee

NEW YORK, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has

Shareholder rights law firm [url="]Robbins LLP[/url] reminds investors that a class action was filed

SAN DIEGO--(BUSINESS WIRE)---- $GUTS #Fractyl--Shareholder rights law firm Robbins LLP reminds inves

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

Pension funds, asset managers, and other fiduciaries holding Fractyl Health (NASDAQ: GUTS) during th

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has

New class action for GoDaddy (GDDY) urges investors to seek recovery for alleged securities fraud vi

Two named officers of Fractyl Health, Inc. — Co-Founder and CEO Harith Rajagopalan and former CFO Li

NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor

Fractyl Health, Inc. (GUTS) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Tran

LOS ANGELES, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors

Allegations focus on two public offerings in August and September 2025 that allegedly raised approxi

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff

NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogn

Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.16) per share which missed the analyst

Fractyl Health reported one-year REMAIN-1 data showing Revita reduced weight regain after GLP-1 ther

Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday&#3

Key Findings:Dose-dependent durability confirmed at one year: In the full modified intention-to-trea

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a B

Participants retained ~78% of GLP-1 induced total body weight loss one year after discontinuation an

Fractyl Health (NASDAQ:GUTS) reported quarterly earnings of $0.06 per share which beat the analyst c

Authorization advances Fractyl Health to a dual clinical-stage company, with Revita in pivotal devel

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a B

Fractyl Health's shares jumped 20.9% after hours following its Q4 2025 results and new weight-ma

Fractyl Health (NASDAQ:GUTS) reported quarterly losses of $(0.07) per share which beat the analyst c

Topline 6-month pivotal data expected in early Q4 2026 with potential FDA marketing application subm

Morgan Stanley analyst Michael Ulz downgrades Fractyl Health (NASDAQ:GUTS) from Overweight to Equ

Fractyl Health stock plunged after the company signaled a possible FDA path change for its Revita de

Revita-treated patients experienced sustained weight maintenance, improved cardiometabolic profile,

RevitaIn 2026, the Company plans to advance Revita through a series of important clinical and regula